The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts.

The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts. Abstract Text:

Christiane Ferran,

The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts. Publishing Authors By Initials

C Ferran,

For similar surgical procedures, operative: transplantation: transplantation, homologous research abstracts see: surgical procedures, operative: transplantation: transplantation, homologous research

PUBMED ID PMID:

MEDLINE DATE:

The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Transplant immunology

VOLUME: 9

Page Numbers: 135-6

Journal Abbreviation: Transpl. Immunol.

ISSN: 0966-3274

DAY: 9

MONTH: May

YEAR: 2002

The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9309923

The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts. Keywords Mesh Terms:

KEYWORDS: Transplantation, Homologous

MESH TERMS: physiology

Chemical & Substance for Abstract: The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts. Information

Substance Name: TNFAIP3 protein, human

Registry Number: EC 6.3.2.19

Grant and Affiliation Information for The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts.

AFFILIATION: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. cferran@caregroup.harvard.edu

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Transpl Immunol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts Related Publications

• A novel function for A20 in smooth muscle cells: inhibition of activation and proliferation.
• A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism.
• A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets.
• A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation.
• A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis.
• A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis.
• A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism.
• A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia.
• Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells.
• Expression of protective genes in human renal allografts: a regulatory response to injury associated with graft rejection.
• Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function.
• Management of acute and chronic ankle instability.
• The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts.
• The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells.
• [Not Available.]